Cargando…
Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site
The structure-specific nuclease human flap endonuclease-1 (hFEN1) plays a key role in DNA replication and repair and may be of interest as an oncology target. We present the first crystal structure of inhibitor-bound hFEN1 and show a cyclic N-hydroxyurea bound in the active site coordinated to two m...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348030/ https://www.ncbi.nlm.nih.gov/pubmed/27526030 http://dx.doi.org/10.1038/nchembio.2148 |
_version_ | 1782514162005442560 |
---|---|
author | Exell, Jack C. Thompson, Mark J. Finger, L. David Shaw, Steven J. Debreczeni, Judit Ward, Thomas A. McWhirter, Claire Siöberg, Catrine L. B. Martinez Molina, Daniel Mark Abbott, W. Jones, Clifford D. Nissink, J. Willem M. Durant, Stephen T. Grasby, Jane A. |
author_facet | Exell, Jack C. Thompson, Mark J. Finger, L. David Shaw, Steven J. Debreczeni, Judit Ward, Thomas A. McWhirter, Claire Siöberg, Catrine L. B. Martinez Molina, Daniel Mark Abbott, W. Jones, Clifford D. Nissink, J. Willem M. Durant, Stephen T. Grasby, Jane A. |
author_sort | Exell, Jack C. |
collection | PubMed |
description | The structure-specific nuclease human flap endonuclease-1 (hFEN1) plays a key role in DNA replication and repair and may be of interest as an oncology target. We present the first crystal structure of inhibitor-bound hFEN1 and show a cyclic N-hydroxyurea bound in the active site coordinated to two magnesium ions. Three such compounds had similar IC(50) values but differed subtly in mode of action. One had comparable affinity for protein and protein–substrate complex and prevented reaction by binding to active site catalytic metal ions, blocking the unpairing of substrate DNA necessary for reaction. Other compounds were more competitive with substrate. Cellular thermal shift data showed engagement of both inhibitor types with hFEN1 in cells with activation of the DNA damage response evident upon treatment. However, cellular EC(50)s were significantly higher than in vitro inhibition constants and the implications of this for exploitation of hFEN1 as a drug target are discussed. |
format | Online Article Text |
id | pubmed-5348030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-53480302017-03-23 Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site Exell, Jack C. Thompson, Mark J. Finger, L. David Shaw, Steven J. Debreczeni, Judit Ward, Thomas A. McWhirter, Claire Siöberg, Catrine L. B. Martinez Molina, Daniel Mark Abbott, W. Jones, Clifford D. Nissink, J. Willem M. Durant, Stephen T. Grasby, Jane A. Nat Chem Biol Article The structure-specific nuclease human flap endonuclease-1 (hFEN1) plays a key role in DNA replication and repair and may be of interest as an oncology target. We present the first crystal structure of inhibitor-bound hFEN1 and show a cyclic N-hydroxyurea bound in the active site coordinated to two magnesium ions. Three such compounds had similar IC(50) values but differed subtly in mode of action. One had comparable affinity for protein and protein–substrate complex and prevented reaction by binding to active site catalytic metal ions, blocking the unpairing of substrate DNA necessary for reaction. Other compounds were more competitive with substrate. Cellular thermal shift data showed engagement of both inhibitor types with hFEN1 in cells with activation of the DNA damage response evident upon treatment. However, cellular EC(50)s were significantly higher than in vitro inhibition constants and the implications of this for exploitation of hFEN1 as a drug target are discussed. 2016-08-15 2016-10 /pmc/articles/PMC5348030/ /pubmed/27526030 http://dx.doi.org/10.1038/nchembio.2148 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Exell, Jack C. Thompson, Mark J. Finger, L. David Shaw, Steven J. Debreczeni, Judit Ward, Thomas A. McWhirter, Claire Siöberg, Catrine L. B. Martinez Molina, Daniel Mark Abbott, W. Jones, Clifford D. Nissink, J. Willem M. Durant, Stephen T. Grasby, Jane A. Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site |
title | Cellular Active N-Hydroxyurea FEN1 Inhibitors Block
Substrate Entry to the Active Site |
title_full | Cellular Active N-Hydroxyurea FEN1 Inhibitors Block
Substrate Entry to the Active Site |
title_fullStr | Cellular Active N-Hydroxyurea FEN1 Inhibitors Block
Substrate Entry to the Active Site |
title_full_unstemmed | Cellular Active N-Hydroxyurea FEN1 Inhibitors Block
Substrate Entry to the Active Site |
title_short | Cellular Active N-Hydroxyurea FEN1 Inhibitors Block
Substrate Entry to the Active Site |
title_sort | cellular active n-hydroxyurea fen1 inhibitors block
substrate entry to the active site |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348030/ https://www.ncbi.nlm.nih.gov/pubmed/27526030 http://dx.doi.org/10.1038/nchembio.2148 |
work_keys_str_mv | AT exelljackc cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT thompsonmarkj cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT fingerldavid cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT shawstevenj cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT debreczenijudit cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT wardthomasa cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT mcwhirterclaire cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT siobergcatrinelb cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT martinezmolinadaniel cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT markabbottw cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT jonescliffordd cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT nissinkjwillemm cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT durantstephent cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite AT grasbyjanea cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite |